The Messersmith lab implements a personalized approach in developing new anticancer drugs for gastrointestinal cancers by using novel colorectal and pancreatic explant models.
The Pitts (GI Translational Research) lab is focused on developing new novel therapies for colorectal and pancreatic cancers and in finding rational combination partners for molecularly-targeted anticancer and immunotherapy agents.
.png?sfvrsn=abfc74b4_0 "Carlo Marchetti")
86210be9302864d9a5bfff02001ce385.png?sfvrsn=49096fb5_0 "Cameron Pywell")
f91296e8302864d9a5bfff02001ce385.jpg?sfvrsn=363af2b4_0 "John Tentler")
2fa6f8e8302864d9a5bfff02001ce385.png?sfvrsn=e08e9cb4_0 "Margaret Wheless, MD")